Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“Please Join Us:
Translating HER2 – Directed Therapy in Biliary Tract Cancer
March 2, 2026 9:00 AM ET | 3:00 PM CET
Presented by:
ICRN/ENS – CCA Translational Science Seminar Series
Speaker(s):
“Redirecting the Immune System against Tumor Cells”
Professor Joaquín Arribas, Group Leader, Vall d’Hebron Institute of Research (VHIR) – Vall d’Hebron Institut de Recerca
“Clinical Advances in HER2 – Directed Therapy”
Dr. Funda Meric – Bernstam, Department of Investigational Cancer Therapeutics, MD Anderson
Moderators:
Prof. Juan Valle, Chief Medical Officer, Cholangiocarcinoma Foundation, and Dr. Anna Saborowski, Senior Physician & Head, Molecular Tumour Board, Hannover Medical School
Partners:
European COST – Action Precision – BTC – Network (linked with ENSCCA – the European Network for the Study of Cholangiocarcinoma)”
More posts featuring Juan W. Valle